Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mounties on aristolochic acid watch

This article was originally published in The Tan Sheet

Executive Summary

Health Canada asks the Canadian Border Services Agency to prevent the importation of aristolochic acid-containing products and advises consumers not to use the "naturally occurring toxin that can cause cancer, mutations in human cells and end-stage kidney failure." Health Canada first issued a warning about the ingredient in 1999 and is "determining whether these products are being sold on the Canadian market," the agency notes July 26. FDA issued an import alert in 2000 for detention of aristolochic acid products 1("The Tan Sheet" July 17, 2000, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097116

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel